WHO Committee Adopts Weakened Draft Resolution On Drug Pricing Transparency
Reuters: WHO agrees watered-down resolution on transparency in drug costs
“World Health Organization members agreed on Tuesday to push for clearer drug pricing but stepped back from proposals by activists to force pharmaceutical firms to disclose the cost of making medicines. … An earlier draft of the text would have given the WHO explicit powers to collect and analyze data on procurement prices and costs from clinical trials. But that wording was omitted from a draft published on Tuesday. A WHO committee adopted the draft by consensus after a long negotiation, just in time for it to be considered by the WHO’s annual assembly which was due to close later on Tuesday…” (Miles, 5/28).